DEC 06, 2018 03:00 PM CET
Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar

Overview of the main hormones associated with alteration of bone and mineral metabolism in patients with chronic kidney disease

SPONSORED BY: DiaSorin
C.E. CREDITS: P.A.C.E. CE | Florida CE
Speakers
  • Ex head of Laboratoire d'explorations fonctionnelles hôpital Necker-Enfants malades
    Biography
      Now retired (but still active), JCS was the chief of the hormone laboratory in the department of Physiology of the University Necker-Enfants malades hospital in Paris, France, and an invited professor at the Liège University, Belgium. Its main research/clinical topics were the growth hormone/IGFI axis and all aspects of bone and mineral metabolism. He also focused on the importance of vitamin D in many disease other than bone and mineral diseases. He has published more than 300 papers in peer-reviewed journal that are referenced in Pubmed. He was an active member of the scientific committee of the French group of research and information on osteoporosis (GRIO) and a member of the editorial board of several journals.

    Abstract:
    DATE: December 6, 2018
    TIME:  6:00am PST, 9:00am EST, 3:00pm CET
     
    Alterations in the bone and mineral metabolism is of great concern in patients with chronic kidney disease (CKD). As the glomerular filtration rate (GFR) decreases, phosphatemia tends to increase while the renal secretion of the active vitamin D metabolite decreases with, consequently, increases in both serum PTH and FGF23 levels. This the pathophysiological basis of the so-called CKD-bone and mineral disorders (MBD). Experts in Nephrology have published international guidelines, called the KDIGO/CKD-MBD, to help the colleagues to deal with these disorders. In this webinar, the KDIGO recommendations concerning the measurement of the serum concentration of PTH, vitamin D metabolites and FGF23 will be discussed.
     
    Learning Objective:
    • Understand the bone metabolic disorder in CKD patients
    • Which is the mechanism that regulate the calcium and phosphorus absorption in patient with altered hormone activities
    • Know the utility of a few fundamental markers to decide the CKD patient management

    Show Resources
    You May Also Like
    MAY 24, 2018 09:30 AM PDT
    C.E. CREDITS
    MAY 24, 2018 09:30 AM PDT
    DATE: May 24, 2018 TIME: 9:30PM PDT The current gold standard in in vitro pre-clinical cancer treatment screening remain cell lines,...
    MAY 02, 2018 08:00 AM PDT
    C.E. CREDITS
    MAY 02, 2018 08:00 AM PDT
    Immunohistochemistry protocols, which utilize antibodies to visualize proteins in tissue sections, have many steps that need optimized to prevent non-specific background effects, artifacts, o...
    MAY 22, 2018 08:00 AM PDT
    C.E. CREDITS
    MAY 22, 2018 08:00 AM PDT
    DATE: May 22, 2018TIME: 08:00AM PDT The nuclear receptors pregnane X receptor (PXR) and constitutive androstane receptor (CAR) are closely related transcription factors that...
    APR 25, 2018 07:00 AM PDT
    C.E. CREDITS
    APR 25, 2018 07:00 AM PDT
    DATE: April 25, 2018TIME: 1500 CET, 10:00 a.m. EST, 7:00 a.m. PST Hematology and coagulation laboratories perform a wide range of routine and specialized tests, allowing clinicians to...
    MAY 03, 2018 11:00 AM PDT
    MAY 03, 2018 11:00 AM PDT
    DATE: May 3, 2018TIME: 11:00AM PDT, 2:00PM EDTWhile stress is one of the leading causes of neuropsychiatric disorders, the molecular underpinnings of how stress induces alterations in b...
    JUN 26, 2018 06:00 AM PDT
    C.E. CREDITS
    JUN 26, 2018 06:00 AM PDT
    Date: June 26, 2018Time: 6:00 a.m. PDT, 9:00 a.m. EDT, 1500 CEST Today’s hematology analyzers employ various methods for enumerating platelets. These methods include: e...
    Loading Comments...